The placebo effect and its determinants in fibromyalgia: meta-analysis of randomised controlled trials

Clinical Rheumatology

Volumn 36, Issue 7, 2017, Pages 1623-1630

  Chen, Xi ^a   Zou, Kun ^a   Abdullah, Natasya ^a   Whiteside, Nicola ^a   Sarmanova, Aliya ^a   Doherty, Michael ^a   Zhang, Weiya ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Fibromyalgia; Meta analysis; Pain management; Placebo effect; Rheumatic diseases; Systematic reviews and methodology

Indexed keywords

PLACEBO;

AGE; ANALGESIA; ARTICLE; DISEASE DURATION; FATIGUE; FIBROMYALGIA; GENDER; HUMAN; META ANALYSIS; PAIN; PAIN SEVERITY; PLACEBO EFFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP QUALITY; SOCIAL DETERMINANTS OF HEALTH; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; PATHOPHYSIOLOGY; PSYCHOLOGY;

FIBROMYALGIA; HUMANS; PAIN MANAGEMENT; PLACEBO EFFECT;

EID: 85015180453     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-017-3595-8     Document Type: Article

References (43)

1. Pozgain I, Pozgain Z, Degmecic D (2014) Placebo and nocebo effect: a mini-review. Psychiatr Danub 26(2):100–107
2. Yunus MB (2001) The role of gender in fibromyalgia syndrome. Curr Rheumatol Rep 3(2):128–134
3. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 62(5):600–610
4. McBeth J, Macfarlane GJ, Benjamin S, Silman AJ (2001) Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 44(4):940–946
5. Kirsch I (2014) Antidepressants and the placebo effect. Zeitschrift Fur Psychologie 222(3):128–134
6. Hauser W, Hansen E, Enck P (2012) Nocebo phenomena in medicine: their relevance in everyday clinical practice. Deutsches Arzteblatt international 109(26):459–465
7. LeWitt PA, Kim S (2015) The pharmacodynamics of placebo: expectation effects of price as a proxy for efficacy. Neurology 84(8):766–767
8. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE et al (2008) Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 336(7651):999–1003
9. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M (2008) The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 67(12):1716–1723
10. Suarez-Almazor ME, Looney C, Liu Y, Cox V, Pietz K, Marcus DM et al (2010) A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider communication. Arthritis Care & Research 62(9):1229–1236
11. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome2008 2008–05-01 22:01:28. 999–1003 p.
12. Furukawa TA (2002 Feb) Review: placebo is better than no treatment for subjective continuous outcomes and for treatment of pain. Evidence Based Mental Health 5(1):15
13. Hauser W, Bartram-Wunn E, Bartram C, Reinecke H, Tolle T (2011) Systematic review: placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors. Pain 152(8):1709–1717
14. Ingham SL, Zhang W, Doherty SA, McWilliams DF, Muir KR, Doherty M (2011) Incident knee pain in the Nottingham community: a 12-year retrospective cohort study. Osteoarthr Cartil 19(7):847–852
15. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale, N.J
16. Hedges LV (1981) Distribution theory for Glass’s estimator of effect size and related estimators. J Educ Stat 6(2):107–128
17. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315(7109):629–634
18. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J 327(7414):557–560
19. Whitehead A (2002) Meta-analysis of controlled clinical trials. Wiley, Chichester, 336 p
20. Beecher HK (1955) The powerful placebo. Jama-Journal of the American Medical Association 159(17):1602–1606
21. Last JM, Adelaide DP (2013) The iceberg: ‘completing the clinical picture’ in general practice. Int J Epidemiol 42(6):1608–1613
22. Stigler SM (1997) Regression towards the mean, historically considered. Stat Methods Med Res 6(2):103–114
23. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P (2007) The Hawthorne effect: a randomised, controlled trial. BMC Med Res Methodol 7:30
24. Kienle GS, Kiene H (1997) The powerful placebo effect: fact or fiction? J Clin Epidemiol 50(12):1311–1318
25. Hrobjartsson A, Gotzsche PC (2001) Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344(21):1594–1602
26. Bootzin RR, Bailey ET (2005) Understanding placebo, nocebo, and iatrogenic treatment effects. J Clin Psychol 61(7):871–880
27. Kirsch I, Weixel LJ (1988) Double-blind versus deceptive administration of a placebo. Behav Neurosci 102:319–323
28. Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR et al (2008) Placebo response in Parkinson’s disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord 23(5):690–699
29. Hauser W, Bartram C, Bartram-Wunn E, Tolle T (2012) Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy systematic review. Clin J Pain 28(5):437–451
30. Flaten MA, Aslaksen PM, Finset A, Simonsen T, Johansen O 2006 Cognitive and emotional factors in placebo analgesia. J Psychosom Res 61(1):81–89
31. Enck P, Bingel U, Schedlowski M, Rief W (2013) The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 12(3):191–204
32. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL 3rd (2009) Sex, gender, and pain: a review of recent clinical and experimental findings. The journal of pain: official journal of the American Pain Society 10(5):447–485
33. Colloca L, Pine DS, Ernst M, Miller FG, Grillon C 2016. Vasopressin boosts placebo analgesic effects in women: a randomized trial. Biological psychiatry. 79(10):794–802
34. Munguia-Izquierdo D, Legaz-Arrese A (2008) Assessment of the effects of aquatic therapy on global symptomatology in patients with fibromyalgia syndrome: a randomized controlled trial. Arch Phys Med Rehabil 89(12):2250–2257
35. Tomas-Carus P, Gusi N, Leal A, Garcia Y, Ortega-Alonso A (2007) The fibromyalgia treatment with physical exercise in warm water reduces the impact of the disease on female patients’ physical and mental health. Reumatologia clinica 3(1):33–37
36. Da Costa D, Abrahamowicz M, Lowensteyn I, Bernatsky S, Dritsa M, Fitzcharles MA et al (2005) A randomized clinical trial of an individualized home-based exercise programme for women with fibromyalgia. Rheumatology (Oxford, England) 44(11):1422–1427
37. Vlahiotis A, Sedjo R, Cox ER, Burroughs TE, Rauchway A, Lich R (2010) Gender differences in self-reported symptom awareness and perceived ability to manage therapy with disease-modifying medication among commercially insured multiple sclerosis patients. Journal of managed care pharmacy: JMCP 16(3):206–216
38. van Koulil S, van Lankveld W, Kraaimaat FW, van Helmond T, Vedder A, van Hoorn H et al (2010) Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res (Hoboken). 62(10):1377–1385
39. Ang DC, Chakr R, Mazzuca S, France CR, Steiner J, Stump T (2010) Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study. Arthritis Care Res (Hoboken) 62(5):618–623
40. Edinger JD, Wohlgemuth WK, Krystal AD, Rice JR (2005) Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med 165(21):2527–2535
41. Carleton RN, Richter AA, Asmundson GJ (2011) Attention modification in persons with fibromyalgia: a double blind, randomized clinical trial. Cogn Behav Ther 40(4):279–290
42. Alexopoulos GS, Kanellopoulos D, Murphy C, Gunning-Dixon F, Katz R, Heo M (2007) Placebo response and antidepressant response. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry 15(2):149–158
43. Cronan TA, Serber ER, Walen HR, Jaffe M (2002) The influence of age on fibromyalgia symptoms. Journal of aging and health 14(3):370–384